Quarterly report pursuant to Section 13 or 15(d)

EQUITY - Activity of Warrants Outstanding (Details)

v3.22.2.2
EQUITY - Activity of Warrants Outstanding (Details)
$ / shares in Units, $ in Thousands
 9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Jan. 25, 2021
$ / shares
Warrants    
Balance at beginning of period (in shares) | shares 69,280,403  
Granted (in shares) $ 400,000  
Exercised (in shares) $ (4,343,846)  
Balance at end of period (in shares) | shares 65,336,557  
Exercisable at end of period (in shares) $ 63,436,557  
Weighted - Average Exercise Price    
Price per share (in dollars per share)   $ 6.85
Proceeds from warrants | $ $ 1,179  
Weighted Average    
Weighted - Average Exercise Price    
Balance at beginning of period (in dollars per share) $ 1.19  
Granted (in dollars per share) 2.20  
Exercised (in dollars per share) 1.26  
Balance at end of period (in dollars per share) 1.19  
Exercisable at end of period (in dollars per share) 1.15  
Price per share (in dollars per share) $ 3.51  
Non-Derivative Warrants    
Warrants    
Balance at beginning of period (in shares) | shares 29,156,048  
Granted (in shares) $ 400,000  
Exercised (in shares) $ (715,846)  
Balance at end of period (in shares) | shares 28,840,202  
Exercisable at end of period (in shares) $ 26,940,202  
Derivative Warrants    
Warrants    
Balance at beginning of period (in shares) | shares 40,124,355  
Granted (in shares) $ 0  
Exercised (in shares) $ (3,628,000)  
Balance at end of period (in shares) | shares 36,496,355  
Exercisable at end of period (in shares) $ 36,496,355  
Weighted - Average Exercise Price    
Balance at end of period (in dollars per share) 1.25  
Senior Notes | Derivative Warrants    
Weighted - Average Exercise Price    
Balance at end of period (in dollars per share) $ 1.25  
Subordinate Voting Shares    
Weighted - Average Exercise Price    
Shares issued upon exercise of warrants (in shares) | shares 3,176,601